CDNA
CDNA
NASDAQ · Biotechnology

Caredx Inc

$56.90
+0.41 (+0.73%)
As of Sep 23, 1:55 PM ET ·
Financial Highlights (FY 2026)
Revenue
370.03M
Net Income
-20,802,666
Gross Margin
67.5%
Profit Margin
-5.6%
Rev Growth
+5.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.5% 67.5% 39.5% 39.5%
Operating Margin -8.1% -7.3% -17.7% -19.5%
Profit Margin -5.6% -5.3% -18.5% -18.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 370.03M 350.14M 329.37M 271.09M
Gross Profit 249.96M 236.52M 130.20M 107.16M
Operating Income -29,972,426 -25,525,343 -58,208,720 -52,994,442
Net Income -20,802,666 -17,716,123 -60,795,749 -51,228,951
Gross Margin 67.5% 67.5% 39.5% 39.5%
Operating Margin -8.1% -7.3% -17.7% -19.5%
Profit Margin -5.6% -5.3% -18.5% -18.9%
Rev Growth +5.7% +5.7% -9.3% +22.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 344.44M 346.18M
Total Equity 455.35M 445.81M
D/E Ratio 0.76 0.78
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,453,082 -24,678,678 -79,903,104 -63,531,119
Free Cash Flow -60,969,564 -57,293,986